Total Payments
$1,890
2024 Payments
$119.27
Companies
9
Transactions
16
Medicare Patients
2,219
Medicare Billing
$486,216
Payment Breakdown by Category
Food & Beverage$1,890 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,890 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $832.69 | 6 | $0 (2020) |
| EISAI INC. | $237.66 | 2 | $0 (2019) |
| EMD Serono, Inc. | $192.05 | 2 | $0 (2023) |
| Grifols USA, LLC | $131.46 | 1 | $0 (2019) |
| Lilly USA, LLC | $119.27 | 1 | $0 (2024) |
| Genentech USA, Inc. | $109.45 | 1 | $0 (2017) |
| Biohaven Pharmaceuticals, Inc. | $96.57 | 1 | $0 (2021) |
| AbbVie Inc. | $89.78 | 1 | $0 (2021) |
| Biogen, Inc. | $80.99 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $119.27 | 1 | Lilly USA, LLC ($119.27) |
| 2023 | $80.45 | 1 | EMD Serono, Inc. ($80.45) |
| 2021 | $267.34 | 3 | Biohaven Pharmaceuticals, Inc. ($96.57) |
| 2020 | $105.81 | 1 | Teva Pharmaceuticals USA, Inc. ($105.81) |
| 2019 | $477.22 | 4 | Grifols USA, LLC ($131.46) |
| 2018 | $364.24 | 3 | Teva Pharmaceuticals USA, Inc. ($239.25) |
| 2017 | $475.59 | 3 | Teva Pharmaceuticals USA, Inc. ($366.14) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $119.27 | General |
| Category: Neuroscience | ||||||
| 02/03/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $80.45 | General |
| Category: Neurology | ||||||
| 11/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $89.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $96.57 | General |
| Category: PRIMARY CARE | ||||||
| 08/25/2021 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $80.99 | General |
| 02/04/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $105.81 | General |
| Category: Central Nervous System | ||||||
| 07/30/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $121.49 | General |
| Category: Central Nervous System | ||||||
| 07/26/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $111.60 | General |
| Category: Neurology | ||||||
| 02/26/2019 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $112.67 | General |
| Category: Neurology | ||||||
| 02/01/2019 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $131.46 | General |
| Category: Immunology and Neurology | ||||||
| 12/01/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $116.14 | General |
| Category: Central Nervous System | ||||||
| 11/28/2018 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Neurology | ||||||
| 10/27/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $123.11 | General |
| Category: Central Nervous System | ||||||
| 08/26/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $183.07 | General |
| Category: Central Nervous System | ||||||
| 08/26/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $183.07 | General |
| Category: Central Nervous System | ||||||
| 05/16/2017 | Genentech USA, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $109.45 | General |
| Category: None | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 126 | 291 | $64,483 | $25,881 |
| 2022 | 4 | 511 | 1,339 | $302,314 | $112,694 |
| 2021 | 4 | 680 | 1,957 | $429,430 | $162,388 |
| 2020 | 5 | 902 | 2,462 | $501,302 | $185,253 |
Total Patients
2,219
Total Services
6,049
Medicare Billing
$486,216
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 180 | $37,843 | $16,134 | 42.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 30 | $12,344 | $3,984 | 32.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 33 | 35 | $7,583 | $3,028 | 39.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 46 | $6,713 | $2,735 | 40.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 159 | 904 | $190,057 | $71,031 | 37.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 130 | 148 | $60,899 | $22,472 | 36.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 119 | 134 | $29,031 | $10,823 | 37.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 103 | 153 | $22,327 | $8,368 | 37.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 198 | 1,227 | $257,964 | $97,744 | 37.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 176 | 195 | $80,239 | $30,000 | 37.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 147 | 349 | $50,930 | $19,361 | 38.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 159 | 186 | $40,297 | $15,283 | 37.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 234 | 1,123 | $236,100 | $87,731 | 37.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 219 | 829 | $120,976 | $44,596 | 36.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 194 | 214 | $88,057 | $32,259 | 36.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 209 | 238 | $51,563 | $18,984 | 36.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 46 | 58 | $4,608 | $1,683 | 36.5% |
About Dr. Madhura Patel, M.D
Dr. Madhura Patel, M.D is a Rehabilitation Practitioner healthcare provider based in Sugarland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366500811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Madhura Patel, M.D has received a total of $1,890 in payments from pharmaceutical and medical device companies, with $119.27 received in 2024. These payments were reported across 16 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,890).
As a Medicare-enrolled provider, Patel has provided services to 2,219 Medicare beneficiaries, totaling 6,049 services with total Medicare billing of $486,216. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Rehabilitation Practitioner
- Location Sugarland, TX
- Active Since 12/05/2006
- Last Updated 10/14/2019
- Taxonomy Code 225400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366500811
Products in Payments
- COPAXONE (Drug) $366.14
- AJOVY (Drug) $360.74
- Fycompa (Drug) $237.66
- Gamunex-C (Biological) $131.46
- KISUNLA (Drug) $119.27
- Mavenclad (Biological) $111.60
- Non-Covered Product (Drug) $109.45
- AJOVY (Biological) $105.81
- NURTEC ODT (Drug) $96.57
- UBRELVY (Drug) $89.78
- MAVENCLAD (Drug) $80.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.